Table 2 Urinary concentrations of unadjusted (ng/mL) and adjusted PAEs (µg/g Cr)
Diether phthalate | Phthalate metabolites (µg/g creatinine) | LOD (ng/mL) | Concentration≥ LOD, n (%) | Median (IQR) | P-Valuea | ||
|---|---|---|---|---|---|---|---|
Total participants (n = 529) | Controls (n = 268) | CHDs Cases (n = 245) | |||||
DiBP | MiBP | 0.50 | 511(99.61%) | 10.23(5.94,17.43) | 10.43(6.09,18.77) | 10.01(5.53,16.12) | 0.452 |
DnBP | MnBP | 0.50 | 513(100%) | 36.9(17.58,71.91) | 34.08(16.6,68.19) | 41.11(19.02,76.23) | 0.106 |
BBzP | MBzP | 0.05 | 434(84.60%) | 0.08(0.04,0.23) | 0.09(0.04,0.19) | 0.08(0.04,0.28) | 0.407 |
DEHP | MEHP | 0.50 | 492(95.90%) | 2.53(1.30,4.58) | 2.71(1.41,4.95) | 2.37(1.19,4.04) | 0.052 |
| Â | MEHHP | 0.05 | 513(100%) | 2.45(1.39,4.11) | 2.35(1.38,3.85) | 2.51(1.41,4.84) | 0.137 |
| Â | MEOHP | 0.05 | 513(100%) | 1.44(0.86,2.45) | 1.40(0.83,2.3) | 1.48(0.88,2.81) | 0.176 |
| Â | MECPP | 0.10 | 513(100%) | 5.48(3.29,9.10) | 5.43(3.25,8.25) | 5.49(3.38,10.36) | 0.219 |
| Â | MCMHP | 0.20 | 513(100%) | 1.59(1.12,2.58) | 1.60(1.16,2.31) | 1.55(1.10,2.89) | 0.489 |